Rare cancers are not so rare: The rare cancer burden in Europe

Share/Save/Bookmark

Gatta, Gemma and Zwan, Jan Maarten van der and Casali, Paolo G. and Siesling, Sabine and Dei Tos, Angelo Paolo and Kunkler, Ian and Otter, Renee and Licitra, Lisa (2011) Rare cancers are not so rare: The rare cancer burden in Europe. European Journal of Cancer, 47 (17). pp. 2493-2511. ISSN 0959-8049

[img] PDF
Restricted to UT campus only
: Request a copy
633kB
Abstract:Purpose: Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cancers in Europe (RARECARE) provides estimates of the incidence, prevalence and survival of rare cancers in Europe based on a new and comprehensive list of these diseases.

Materials and methods: RARECARE analysed population-based cancer registry (CR) data on European patients diagnosed from 1988 to 2002, with vital status information available up to 31st December 2003 (latest date for which most CRs had verified data). The mean population covered was about 162,000,000. Cancer incidence and survival rates for 1995–2002 and prevalence at 1st January 2003 were estimated.

Results: Based on the RARECARE definition (incidence <6/100,000/year), the estimated annual incidence rate of all rare cancers in Europe was about 108 per 100,000, corresponding to 541,000 new diagnoses annually or 22% of all cancer diagnoses. Five-year relative survival was on average worse for rare cancers (47%) than common cancers (65%). About 4,300,000 patients are living today in the European Union with a diagnosis of a rare cancer, 24% of the total cancer prevalence.

Conclusion: Our estimates of the rare cancer burden in Europe provide the first indication of the size of the public health problem due to these diseases and constitute a useful base for further research. Centres of excellence for rare cancers or groups of rare cancers could provide the necessary organisational structure and critical mass for carrying out clinical trials and developing alternative approaches to clinical experimentation for these cancers.
Item Type:Article
Copyright:© 2011 Elsevier
Faculty:
Management and Governance (SMG)
Research Group:
Link to this item:http://purl.utwente.nl/publications/78337
Official URL:http://dx.doi.org/10.1016/j.ejca.2011.08.008
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page